BS AJAIKUMAR
KKR to acquire Medicover India in $1.5 billion deal
The transaction includes a sale of 100% stake by existing shareholders, as well as a commitment to deploy fresh capital to fund its growth and repay debt. In all, KKR will be spending Rs 13,000-14,000 crore, around quarter of which (Rs 3,000-4,000 crore) will go into the company as primary capital, said people aware of developments.
HCG uses AI, patient data to personalise cancer treatment: BS Ajaikumar, founder
Healthcare Global Enterprises is using artificial intelligence and patient data. Algorithms are being developed to personalise cancer treatment and improve outcomes. The company analyses clinical and genomic data to classify patients for better decisions. HCG partnered with Accenture to enhance its AI research capabilities.
KKR to buy cancer care hospital chain HCG from CVC for $400 million
KKR acquires a controlling stake in Healthcare Global from CVC Capital Partners for Rs 3466 crore, strengthening its presence in the healthcare sector. The deal gives KKR up to 77% ownership, and Dr. BS Ajaikumar will take on a new role as Non-Executive Chairman.
KKR set to buy cancer chain HCG
KKR is set to acquire a 51% stake in Healthcare Global Enterprises from CVC Capital Partners. The $3,128 crore deal includes an open offer for an additional 26%. HCG's founding family will retain 10.87%, while the company's growth trajectory and expanded capabilities are expected post-acquisition.
KKR close to buying cancer chain HCG
KKR is close to acquiring a 60.36% stake in Healthcare Global Enterprises Ltd (HCG), trumping Bain Capital's bid. The acquisition from CVC Capital is worth ₹4,663.12 crore. The deal includes a potential open offer for an additional 26% of HCG, possibly leading to the delisting of the hospital chain.
HCG founder floats $20 million healthcare and life sciences fund
BS Ajaikumar launched the $20 million Inviga Healthcare Fund to support Indian early-stage healthcare companies, addressing funding and operational challenges. The fund recently invested $2 million in Mynvax for novel vaccines.
- Go To Page 1
Dr BS Ajaikumar on CVC selling Healthcare Global controlling stake, future plans and more
Dr BS Ajaikumar, Executive Chairman of Healthcare Global, is focused on achieving margin and expects growth. HCG plans to do more M&As and is looking for a long-term partner. There is potential for significant growth in oncology, driven by increased private insurance and expansion into tier II and III cities.
Choice Equity Broking neutral on Healthcare Global Enterprises, target price: Rs 306
Healthcare Global Enterprises, incorporated in the year 1998, is a Small Cap company (having a market cap of Rs 4113.66 Crore) operating in Hospitals & Allied Services sector.
Healthcare Global Enterprise to focus on footfalls, asset use to increase profit
The Bengaluru-based cancer care provider has been in scale-up mode setting up new cancer centres till FY19, but just as it was trying to ramp up operations at new centres, it was hit by covid related headwinds. With the pandemic wearing off, HCG is seeing strong momentum in growth and profitability. The company said it was targeting 18-20% return on capital employed in the next 2-3 years from the current 14%. HCG saw 23% YoY growth in H1FY23 to ₹828 crore.
HealthCare Global acquires majority stake in Suchirayu Healthcare
Suchirayu owns a multi-speciality hospital in Hubli with an operational capacity of 110 beds and a potential to scale up to 250 beds. HCG has operated and maintained the hospital since August 2017 and had the right to increase its stake up to 80 per cent, the statement said.
Anthill Ventures and HCG announce 6 startups for ‘Lumos Health’ programme
The programme is designed to help startups focused on emerging technologies in healthcare and life sciences accelerate their business growth by providing them support and mentorship.
Cancer Care: HCG signs up with Stanford University
Stanford University has already implemented outcome based treatment in the US, the hospital group said in a press release.
Price cuts to hit quality of cancer care: HCG CEO
HCG has filed a writ petition with the Karnataka High Court challenging the decision of the National Pharmaceutical Pricing Control.
Private hospitals want government to review rates of insurance scheme
Branded as Modicare earlier, the Ayushman Bharat scheme flagged the world’s largest insurance scheme.
Make these 5 lifestyle changes and choices to lower your risk of cancer
To reduce risk of cancer, you need to be aware of many factors that work together to cause cancer and then do your best to reduce exposure.
Healthcare's dilemma: Balancing public needs with business sense
With scrutiny over quality & affordability of healthcare becoming an issue, the question of balancing needs with commercial aspirations have polarised the industry.
HealthCare, Arogya bring zero-interest loan for patients
Patients can borrow money either in the form of direct financial loans or in the form of loan cards, with an embedded pre-approved loan.
Healthcare Global likely to clock 25%-plus growth in next few years: BS Ajaikumar, CEO
"From 17 comprehensive cancer centres today, we will soon be 26 centres. That should lead to high growth for the group overall over the next few years."
Wipro veteran Suresh Senapaty to join HCG board
In 2010, Premji Invest had invested around $20 million in the company. Since then, HCG has grown to become India’s largest cancer specialty chain.
Hyderabad startup Fournira Optime Diagnostics says it can detect breast cancer through blood test
The company, which is less than a year old, has completed initial trials using its diagnostic kit to detect the disease in about 200 women so far.
HealthCare Global buys major stake in Bangalore Assisted Conception Centre
The company founded in 1990 by Kamini A. Rao operates four fertility centers across Bangalore and will now be rebranded as Milann – The Fertility Center.
Temasek invests Rs 130 cr in HealthCare Global Enterprises
Sources said Temasek has made an investment of Rs 130 crore in the Indian firm, which is a specialist in cancer care.
Temasek Holdings invests Rs 140 crore in HealthCare Global Enterprises
Temasek joins existing investors Premji Invest, a firm owned by Azim Premji, and Milestone Religare in a primary equity issuance by the company.
InterGlobe Enterprises' Rahul Bhatia wins Ernst & Young Entrepreneur of the Year Award 2011
Rahul Bhatia, Group Managing Director, InterGlobe Enterprises, was on Thursday named as the Ernst & Young Entrepreneur of The Year 2011.
Load More
